Aug 22, 2018
iHuman Team at ShanghaiTech University Deciphers the First Human Frizzled Receptor Structure
Aug 09, 2018
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease
Jun 27, 2018
Beacon Discovery Announces Partnership With Escient Pharmaceuticals And Expansion Of Its San Diego Facility
May 23, 2018
Sosei Collaboration with PeptiDream Progressing Well
Apr 19, 2018
Neuropeptide Y Y1 receptor Structures Offer New Opportunities for Anti-obesity Drug Discovery
Feb 27, 2018
Beacon Discovery announces multi-year GPCR drug discovery collaboration with Takeda focused on gastrointestinal disorders
Jan 04, 2018
Beacon Discovery announces multi-year GPCR-focused drug discovery collaboration with Janssen Pharmaceuticals
Jan 04, 2018
Heptares Scientists Solve Structure of Complement C5a Receptor, an Important Drug Target for Inflammatory and Neurodegenerative Diseases, and Cancer
Jan 03, 2018
Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery
Dec 19, 2017
Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche
Oct 05, 2017
Heptares Founder Richard Henderson Receives Nobel Prize in Chemistry 2017 for Pioneering Work in Cryo-EM for Visualising Biological Structures
Aug 31, 2017
Heptares Enters a New Research and Drug Discovery Collaboration Under its 'Orbit' Initiative with Juntendo University
Jun 29, 2017
Heptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease
Jun 28, 2017
Heptares Enters a New Research and Drug Discovery Collaboration Under its "Orbit" Initiative With New York University School of Medicine